Citations to this article
Citation Information: JCI Insight. 2019;4(13):e126925. https://doi.org/10.1172/jci.insight.126925.
Abstract
BACKGROUND Sphingolipids (SPs) are ubiquitous, structurally diverse molecules that include ceramides, sphingomyelins (SMs), and sphingosines. They are involved in various pathologies, including obesity and type 2 diabetes mellitus (T2DM). Therefore, it is likely that perturbations in plasma concentrations of SPs are associated with disease. Identifying these associations may reveal useful biomarkers or provide insight into disease processes.METHODS We performed a lipidomics evaluation of molecularly distinct SPs in the plasma of 2302 ethnically Chinese Singaporeans using electrospray ionization mass spectrometry coupled with liquid chromatography. SP profiles were compared to clinical and biochemical characteristics, and subjects were evaluated with follow-up visits for 11 years.RESULTS We found that ceramides correlated positively but hexosylceramides correlated negatively with BMI and homeostatic model assessment of insulin resistance (HOMA-IR). Furthermore, SPs with a d16:1 sphingoid backbone correlated more positively with BMI and HOMA-IR, while d18:2 SPs correlated less positively, relative to canonical d18:1 SPs. We also found that higher concentrations of 2 distinct SMs were associated with a higher risk of T2DM (HR 1.45 with 95% CI 1.18–1.78 for SM d16:1/18:0 and HR 1.40 with 95% CI 1.17–1.68 for SM d18:1/18:0).CONCLUSIONS We identified significant associations between SPs and obesity/T2DM characteristics, specifically, those of hexosylceramides, d16:1 SPs, and d18:2 SPs. This suggests that the balance of SP metabolism, rather than ceramide accumulation, is associated with the pathology of obesity. We further identified 2 specific SPs that may represent prognostic biomarkers for T2DM.FUNDING National University Health System (NUHSRO/2014/085/AF-Partner/01) and the National Research Foundation Investigatorship grant (NRF-NRFI2015-05).
Authors
Wee Siong Chew, Federico Torta, Shanshan Ji, Hyungwon Choi, Husna Begum, Xueling Sim, Chin Meng Khoo, Eric Yin Hao Khoo, Wei-Yi Ong, Rob M. Van Dam, Markus R. Wenk, E. Shyong Tai, Deron R. Herr
Total citations by year
Citations to this article in year 2023 (20)
| Title and authors | Publication | Year |
|---|---|---|
|
Metabolic Phenotyping of BMI to Characterize Cardiometabolic Risk and Outcomes in Large Population Cohorts
Habtamu Beyene, Gavriel Olshansky, Corey Giles, Kevin Huynh, Michelle Cinel, Natalie Mellett, Alexander Smith, Thomas Meikle, Gerald Watts, Joseph Hung, Jennie Hui, Gemma Cadby, John Beilby, John Blangero, Eric Moses, Jonathan Shaw, Dianna Magliano, Peter Meikle |
Nature Communications | 2023 |
|
The Dark Side of Sphingolipids: Searching for Potential Cardiovascular Biomarkers
Di Pietro P, Izzo C, Abate AC, Iesu P, Rusciano MR, Venturini E, Visco V, Sommella E, Ciccarelli M, Carrizzo A, Vecchione C |
Biomolecules | 2023 |
|
Integrated lipids biomarker of the prediabetes and type 2 diabetes mellitus Chinese patients
Yang J, Wang M, Yang D, Yan H, Wang Z, Yan D, Guo N |
Frontiers in Endocrinology | 2023 |
|
Plasma Sphingoid Base Profiles of Patients Diagnosed with Intrinsic or Idiosyncratic Drug-induced Liver Injury
Gai Z, Samodelov SL, Alecu I, Hornemann T, Grove JI, Aithal GP, Visentin M, Kullak-Ublick GA |
International journal of molecular sciences | 2023 |
|
Plasma lipidomic profiling reveals metabolic adaptations to pregnancy and signatures of cardiometabolic risk: a preconception and longitudinal cohort study
Chen L, Mir SA, Bendt AK, Chua EW, Narasimhan K, Tan KM, Loy SL, Tan KH, Shek LP, Chan J, Yap F, Meaney MJ, Chan SY, Chong YS, Gluckman PD, Eriksson JG, Karnani N, Wenk MR |
BMC Medicine | 2023 |
|
The roles of dietary lipids and lipidomics in gut-brain axis in type 2 diabetes mellitus
Ağagündüz D, Icer MA, Yesildemir O, Koçak T, Kocyigit E, Capasso R |
Journal of Translational Medicine | 2023 |
|
Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes
Denimal D, Bergas V, Pais-de-Barros JP, Simoneau I, Demizieux L, Passilly-Degrace P, Bouillet B, Petit JM, Rouland A, Bataille A, Duvillard L, Vergès B |
Cardiovascular Diabetology | 2023 |
|
Extracellular vesicles from human plasma for biomarkers discovery: Impact of anticoagulants and isolation techniques.
Bettio V, Mazzucco E, Antona A, Cracas S, Varalda M, Venetucci J, Bruno S, Chiabotto G, Venegoni C, Vasile A, Chiocchetti A, Quaglia M, Camussi G, Cantaluppi V, Panella M, Rolla R, Manfredi M, Capello D |
PloS one | 2023 |
|
Enhancing de novo ceramide synthesis induced by bisphenol A exposure aggravates metabolic derangement during obesity
Wang G, Hong X, Yu J, Zhang Y, Li Y, Li Z, Zhu Z, Yuan S, Zhang X, Wang S, Zhu F, Wang Y, Wu C, Su P, Shen T |
Molecular Metabolism | 2023 |
|
Replacement of dietary saturated with unsaturated fatty acids is associated with beneficial effects on lipidome metabolites: a secondary analysis of a randomized trial
Sellem L, Eichelmann F, Jackson KG, Wittenbecher C, Schulze MB, Lovegrove JA |
The American journal of clinical nutrition | 2023 |
|
Hibernation and plasma lipids in free-ranging brown bears-implications for diabetes.
Tekin H, Frøbert O, Græsli AR, Kindberg J, Bilgin M, Buschard K |
PloS one | 2023 |
|
Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trials
Wretlind A, Curovic VR, de Zawadzki A, Suvitaival T, Xu J, Zobel EH, von Scholten BJ, Ripa RS, Kjaer A, Hansen TW, Vilsbøll T, Vestergaard H, Rossing P, Legido-Quigley C |
Lipids in Health and Disease | 2023 |
|
Association of healthy dietary patterns and cardiorespiratory fitness in the community
Mi MY, Gajjar P, Walker ME, Miller P, Xanthakis V, Murthy VL, Larson MG, Vasan RS, Shah RV, Lewis GD, Nayor M |
European Journal of Preventive Cardiology | 2023 |
|
Ceramides as Risk Markers for Future Cardiovascular Events and All-Cause Mortality in Long-standing Type 1 Diabetes
Wretlind A, Curovic VR, Suvitaival T, Theilade S, Tofte N, Winther SA, Vilsbøll T, Vestergaard H, Rossing P, Legido-Quigley C |
Diabetes | 2023 |
|
Plasma metabolomics supports non-fasted sampling for metabolic profiling across a spectrum of glucose tolerance in the Nile rat model for type 2 diabetes
Anderson BJ, Curtis AM, Jen A, Thomson JA, Clegg DO, Jiang P, Coon JJ, Overmyer KA, Toh H |
Lab Animal | 2023 |
|
Lipidomics analysis of impaired glucose tolerance and type 2 diabetes mellitus in overweight or obese elderly adults.
Shao F, Hu X, Li J, Bai B, Tian L |
Endocrine Connections | 2023 |
|
Lipidomics profiling reveals distinct patterns of plasma sphingolipid alterations in Alzheimer’s disease and vascular dementia
Chua XY, Torta F, Chong JR, Venketasubramanian N, Hilal S, Wenk MR, Chen CP, Arumugam TV, Herr DR, Lai MK |
Alzheimer's research & therapy | 2023 |
|
Blood-Derived Lipid and Metabolite Biomarkers in Cardiovascular Research from Clinical Studies: A Recent Update
Kale D, Fatangare A, Phapale P, Sickmann A |
Cells | 2023 |
|
Associations of plasma sphingolipids with measures of insulin sensitivity, β-cell function, and incident diabetes in Japanese Americans
Bae JC, Wander PL, Lemaitre RN, Fretts AM, Sitlani CM, Bui HH, Thomas MK, Leonetti D, Fujimoto WY, Boyko EJ, Utzschneider KM |
Nutrition, Metabolism, and Cardiovascular Diseases | 2023 |
|
Ten metabolites-based algorithm predicts the future development of type 2 diabetes in Chinese.
Su X, Cheung CYY, Zhong J, Ru Y, Fong CHY, Lee CH, Liu Y, Cheung CKY, Lam KSL, Xu A, Cai Z |
Journal of advanced research | 2023 |
